Everything important about our purpose and mission, the business and the people who shape CompuGroup Medical.
Purpose & Mission
Information, downloads and contacts for representatives of press and other media.
We promote dialog in the healthcare sector and ensure that costs are saved in a meaningful way. Everyone should benefit from medical progress with the help of IT.
This page is not compatible with Internet Explorer.
For security reasons, we recommend that you use an up-to-date browser, e.g. Microsoft Edge, Google Chrome, Safari, or Mozilla Firefox.
We are happy to support you and your IT in switching to a modern and secure operating system and browser.
CompuGroup Medical SE & Co. KGaA has announced with today's publication of its Annual Report for the fiscal year (FY) 2021 that the Executive Directors and the Supervisory Board intend to propose a dividend of EUR 0.50 per share, the same level as last year, at the Annual General Meeting 2022.
"Despite our upfront investments for higher sustained organic growth in the future we were able to generate record free cash flow in FY 2021," commented Michael Rauch, CFO of CompuGroup Medical. "We will continue to use the cash primarily for financing growth as well as returning it to our shareholders in the form of dividends and share buybacks."
Based on the current 52.3 million shares with a dividend entitlement, the estimated total dividend payout will be set at around EUR 26.1 million. Measured against free cash flow and net earnings in 2021, the payout ratio will thus be at around 26 percent. The preliminary figures for FY 2021 and the forecast for 2022 had already been announced on March 10, 2022.
The annual report for FY 2021 is now available to view on the company's website at www.cgm.com/ir-publications.